Personalized medicine strategy for MPNSTs: using precision oncology on PDOX models to inform tumor boards.

J Transl Med · 2026 · PMC12997819 · PMID 41639724

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among the treatment groups, BETi-containing regimens showed a trend toward greater efficacy, resulting in final tumor weights around 600 mg, whereas tumors from MEKi–CDKi combinations reached approximately 1,000 mg (Fig. 4 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.